Research Paper Volume 16, Issue 13 pp 11072—11089
AK7-deficiency reversal inhibits ccRCC progression and boosts anti-PD1 immunotherapy sensitivity
Figure 1. Expression profile of AK7 in tumor. (A) Expression of AK7 mRNA in different cancers and corresponding normal tissues. (B) The expression of AK7 mRNA in ccRCC was significantly higher than that in normal kidney tissue. (C–G) Differences in SPC25 mRNA expression depending on stage, grade, nodal metastasis status, subtype and race. (H) Expression of AK7 in normal renal tissues and ccRCC tissues. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.